Avoro Capital Advisors LLC Madrigal Pharmaceuticals, Inc. Transaction History
Avoro Capital Advisors LLC
- $5.48 Billion
- Q2 2025
A detailed history of Avoro Capital Advisors LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 1,875,000 shares of MDGL stock, worth $818 Million. This represents 10.35% of its overall portfolio holdings.
Number of Shares
1,875,000
Previous 2,022,222
7.28%
Holding current value
$818 Million
Previous $670 Million
15.28%
% of portfolio
10.35%
Previous 10.84%
Shares
21 transactions
Others Institutions Holding MDGL
# of Institutions
355Shares Held
23.2MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$956 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$912 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$870 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$862 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$819 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $7.46B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...